BSECompany Update▲ PositiveResults4 Aug 2026
Mallcom (India) Ltd
Transcript of Q1-FY27 Earnings Conference Call.
Mallcom (India) Ltd announced its Q1-FY27 Earnings Conference Call transcript, highlighting operational highlights, product innovation, and financial performance. The company delivered a meaningful improvement in profitability despite challenging market conditions. Key highlights include the launch of a new mold for EN812 Certified Bump Caps, introduction of European and American certified Flame Retardant workwear, and expansion of the distribution network to over 1,000 resellers across India.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
Avalon Technologies Limited
Outcome of Board Meeting
Avalon Technologies Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, with a revenue from operations of ₹2,106.40 crore and a profit before tax of ₹266.28 crore.
BSECompany Update▲ PositiveResults4 Aug 2026
R Systems International Ltd
As enclosed.
R Systems International Ltd has announced its Q2 and H1 2026 financial results, showing a 30.2% YoY growth in revenue to INR 6,017M and a 51.4% YoY growth in adjusted EBITDA to INR 1,207M. The company's adjusted net profit for Q2 2026 was INR 629M, a 35.4% YoY growth. For H1 2026, revenue grew 30.1% YoY to INR 11,765M, with adjusted EBITDA increasing 51.0% YoY to INR 2,364M.
NSEInvestor Presentation▲ PositiveResults4 Aug 2026
Sudeep Pharma Limited
Investor Presentation
Sudeep Pharma Limited has announced its Q1FY27 results, with revenue growing 27% year-on-year, driven by strong performance across its Pharma, Food & Nutrition, and Specialty Ingredients businesses. The company has also made progress on its strategic growth initiatives, including the Greenfield expansion and Sudeep Advanced Materials (SAM) project.
BSECompany Update▲ PositiveResults4 Aug 2026
Ventive Hospitality Ltd
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 for Investor/Analyst Presentation.
Ventive Hospitality Ltd has announced its Q1 FY27 financial results, with a 7% revenue growth despite a 7% decline in EBITDA due to travel disruptions in West Asia. PAT grew 2.3x due to a one-off tax cost increase.
BSECompany Update▲ PositiveResults4 Aug 2026
Sudeep Pharma Ltd
Submission of revised Investors Presentation
Sudeep Pharma Ltd submitted a revised Investors Presentation for Q1FY27, highlighting a 27% year-on-year revenue growth, driven by operational excellence and strategic growth initiatives.
NSEPress Release▲ PositiveResults4 Aug 2026
Ganesh Consumer Products Limited
Press Release
Ganesh Consumer Products Limited has announced its Q1 FY27 results, with EBITDA margin reaching a record 11.2% and PAT rising 31.4% YoY to ₹125 Mn.
BSECompany Update▲ PositiveResults4 Aug 2026
Ganesh Consumer Products Ltd
Press Release
Ganesh Consumer Products Ltd announced its Q1 FY27 results, with EBITDA margin reaching a record 11.2% and PAT growing 31.4% YoY to ₹125 Mn. The company's total income stood at ₹1,903 Mn, with EBITDA at ₹210 Mn and PAT at ₹125 Mn. The company also announced the launch of its ethnic snacks range and Soya Chunks, and plans to manufacture packaged sweets at its Amta unit.
NSEInvestor Presentation▲ PositiveResults4 Aug 2026
Pondy Oxides & Chemicals Limited
Investor Presentation
Pondy Oxides & Chemicals Limited has released its Q1FY27 investor presentation, highlighting a strong start to the financial year with revenue, EBITDA, and PAT growing by 56%, 30%, and 32% respectively on a YoY basis. The company has prioritized value-added products, resulting in a record lead EBITDA per ton of INR 21,595, up 28% YoY. The company remains on track to achieve its Target 2030 vision, driven by expanded lead capacities, copper capacity additions, and a focus on operational excellence and sustainability.
NSEPress Release▲ PositiveResults4 Aug 2026
R Systems International Limited
Press Release
R Systems International Limited has announced its financial results for the quarter and six months ended June 30, 2026, reporting revenue growth of 30% and EBITDA growth of 51%.
BSECompany Update▲ PositiveResults4 Aug 2026
R Systems International Ltd
As enclosed.
R Systems International Ltd reported robust H1 2026 performance with revenue growth of 30% and EBITDA growth of 51%.
NSEPress Release▲ PositiveM&A4 Aug 2026
Persistent Systems Limited
Press Release
Persistent Systems Limited has informed the Exchange regarding a press release dated August 04, 2026, titled 'Persistent Shareholders Vote for Nagarro Offer'. Shareholders of Persistent Systems Limited approved the proposed Voluntary Public Takeover Offer for Nagarro SE through Persistent's subsidiary, Galaxy Germany Holding SE, along with the related financing arrangements and corporate guarantee at Persistent's Annual General Meeting.
BSECompany Update▲ PositiveM&A4 Aug 2026
Persistent Systems Ltd
The Press release titled ''Persistent Shareholders Vote for Nagarro Offer'', is as enclosed.
Persistent Systems Ltd shareholders approved the proposed acquisition of Nagarro SE through its subsidiary, Galaxy Germany Holding SE, along with the related financing arrangements and corporate guarantee.
NSEPress Release▲ PositiveResults4 Aug 2026
Viviana Power Tech Limited
Press Release
Viviana Power Tech Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue growing 246% YoY to ₹71.86 crore, EBITDA increasing 232% YoY to ₹11.56 crore, and PAT growing 232% YoY to ₹6.93 crore. The company also announced the proposed disinvestment of its entire shareholding in two subsidiaries, Viviana Life Spaces Private Limited and Aarsh Transformers Private Limited.
NSEOutcome of Board Meeting▲ PositiveResults4 Aug 2026
R Systems International Limited
Outcome of Board Meeting
R Systems International Limited has announced its financial results for the quarter and six months ended June 30, 2026, with the company's income at ₹6,030.69 and expenses at ₹5,225.62, resulting in a profit of ₹805.07. The company has also approved the appointment of four new directors and the payment of remuneration to non-executive independent directors.
BSECompany Update▲ PositiveResults4 Aug 2026
Cholamandalam Investment and Finance Company Ltd
Uploaded Transcript of the Earnings Call
Cholamandalam Investment and Finance Company Ltd reported strong growth in Q1 FY27 with aggregate disbursements increasing 22% YoY to INR29,612 crores, AUM expanding 23% YoY to INR2,54,392 crores, and NIMs improving by 42 bps YoY. The company maintained a strong liquidity and capital position with liquid assets of INR23,984 crores and a capital adequacy ratio of 19.81%. The management expressed confidence in achieving the credit cost guidance of 1.5% for FY27.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults4 Aug 2026
Cholamandalam Investment and Finance Company Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Cholamandalam Investment and Finance Company Limited has informed the Exchange about the transcript of the earnings call for the quarter ended 30 June, 2026, where the company reported strong growth in aggregate disbursements, AUM, and profitability, driven by healthy demand trends across all major businesses.
BSECompany Update▲ PositiveResults4 Aug 2026
TPL Plastech Ltd
Press Release dated 04th August, 2026 for Unaudited Financial Results for the Quarter ended 30th June, 2026.
TPL Plastech Ltd reported unaudited financial results for Q1 FY27, with volume growth of 12.1%, revenue from operations of ₹1,243.9 Mn, EBITDA of ₹113.4 Mn, and PAT of ₹65.4 Mn. The company maintained margin stability despite input cost fluctuations and plans to expand its facility in Bhuj.
NSEPress Release▲ PositiveResults4 Aug 2026
TPL Plastech Limited
Press Release
TPL Plastech Limited has reported its unaudited financial results for the quarter ended June 30, 2026, with a 12.1% volume growth, 37.6% revenue growth, and 19.6% profit after tax growth.
NSEGeneral Updates▲ PositiveResults4 Aug 2026
Sanofi India Limited
General Updates
Sanofi India Limited has announced its Q2 2026 financial results, reporting 8% domestic net sales growth and 6% total net sales growth compared to the second quarter of 2025. The company's insulin portfolio delivered double-digit growth of 14% for the second consecutive quarter, driven by strong sales of Lantus, Toujeo, and Apidra. Profits before tax and exceptional items increased 19% to INR 112 crores, with profit before tax as a percentage of net sales improving to 27%.